Disc Medicine, Inc
Clinical trials sponsored by Disc Medicine, Inc, explained in plain language.
-
New drug could let Sunlight-Sensitive patients enjoy the outdoors again
Disease control Recruiting nowThis study is testing whether an investigational drug called bitopertin can help people with rare genetic conditions (EPP or XLP) that cause severe pain from sunlight exposure. Researchers want to see if taking bitopertin for 6 months allows participants to spend more time in the…
Phase: PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Mar 27, 2026 12:47 UTC
-
New drug aims to free blood cancer patients from transfusions
Disease control Recruiting nowThis study is testing an experimental drug called DISC-0974 in people with myelofibrosis or myelodysplastic syndrome who have anemia. The main goals are to see if the drug is safe and if it can help improve red blood cell counts, potentially reducing or eliminating the need for b…
Phase: PHASE1, PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug trial aims to reduce blood draws for rare blood disorder patients
Disease control Recruiting nowThis study is testing an experimental drug called DISC-3405 for people with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells. The trial will enroll 60 adults who currently need frequent blood removal procedures to manage their conditi…
Phase: PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
First human tests begin for potential sickle cell treatment
Disease control Recruiting nowThis early-stage study is testing a new drug called DISC-3405 in 24 adults with sickle cell disease. The main goal is to check if the drug is safe and how the body processes it. Researchers will measure changes in blood markers to see if the drug affects the disease.
Phase: PHASE1 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New drug trial targets debilitating fatigue in IBD patients
Symptom relief Recruiting nowThis study is testing an investigational drug called DISC-0974 for people with inflammatory bowel disease (IBD) who also have anemia, a common condition causing fatigue and weakness. The trial will enroll 21 participants to compare the drug against a placebo, measuring changes in…
Phase: PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Symptom relief
Last updated Apr 01, 2026 23:26 UTC